“99% pure” is one of the most repeated phrases in the research peptide market, and one of the least explained. A purity figure only means something when you know how it was measured, on which lot, and what the measurement can and cannot see. This guide explains the two workhorse techniques behind peptide quality data, HPLC and mass spectrometry, in terms a laboratory buyer can use.
Why Peptides Need Analytical Testing
Synthesis always leaves related impurities. Most research peptides are made by solid-phase synthesis, one residue at a time. D’Hondt and colleagues’ 2014 review in the Journal of Pharmaceutical and Biomedical Analysis describes the impurities this process commonly produces:
- Deletion sequences, where a residue failed to couple
- Insertion sequences, where a residue was added twice
- Diastereomers, from racemization of an amino acid
- Protection adducts, where a side-chain protecting group was not fully removed
- Degradation products, such as oxidized or deamidated forms
Many of these differ from the target by a single residue. They are chemically very similar, which is why specialized separation and detection methods are needed.
HPLC: Measuring Purity
How reversed-phase HPLC works
HPLC separates molecules as they pass through a packed column. In reversed-phase HPLC (RP-HPLC), the most common mode for peptides, the column’s stationary phase is hydrophobic, typically silica bonded with C18 chains. The mobile phase starts mostly aqueous and becomes progressively richer in an organic solvent such as acetonitrile.
More hydrophobic molecules are retained longer. As the organic content rises, each component releases from the column at its own point in the gradient and reaches the detector at a characteristic retention time.
UV detection sees the peptide backbone. Peptide bonds absorb ultraviolet light in the low-UV range, so a UV detector registers nearly all peptide material as it elutes.
From chromatogram to purity percentage
- The detector produces a chromatogram, a plot of absorbance against time.
- Software integrates each peak, measuring the area under it.
- Purity is calculated as area percent: the main peak’s area divided by the total area of all integrated peaks, multiplied by 100.
Example. If the main peak’s area is 9,820 counts and all peaks total 10,000 counts, HPLC purity is 98.2%.
What HPLC purity does not tell you
- It does not measure identity. A large peak shows something is present in abundance, not what it is.
- It does not count non-UV-absorbing material. Water, many salts, and counterions such as trifluoroacetate are not captured in the same way. JPT Peptide Technologies notes that peptides are typically isolated as TFA salts, which is why purity and net peptide content differ.
- Co-eluting impurities can hide. If an impurity leaves the column at the same time as the target, it merges into the main peak and inflates the purity figure.
- Results depend on the method. Column, gradient, and integration settings all influence the number. A purity value without its method is difficult to interpret or compare.
Mass Spectrometry: Confirming Identity
How mass spectrometry works
Mass spectrometry measures the mass-to-charge ratio (m/z) of ions. For peptides, the sample is ionized, most often by electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI). The resulting ions are separated by m/z and detected.
Peptides often carry multiple charges. With ESI, a single peptide may appear as several signals, such as [M+2H]²⁺ and [M+3H]³⁺. The analyst uses these to calculate the neutral molecular mass (M).
Reading an identity result
Compare observed mass with theoretical mass. The theoretical mass is calculated from the sequence and any modifications. If the observed mass matches within the stated tolerance, the main component is consistent with the target.
Monoisotopic vs average mass. High-resolution instruments often report the monoisotopic mass (lightest isotopes only). Lower-resolution results are usually compared with the average mass. A COA should state which is used.
What mass spectrometry does not tell you
- It is not a purity measurement by itself. Ionization efficiency varies between molecules, so signal intensity is not a direct measure of quantity.
- Same-mass variants look alike. Diastereomers from racemization have the same mass as the target, so MS alone cannot distinguish them. Chromatographic separation can often help.
- It can miss what does not ionize well. Some impurities produce weak signals.
LC-MS: Using Both Together
Coupling HPLC to mass spectrometry combines separation with identification. In LC-MS, the column output flows directly into the mass spectrometer. Each peak on the chromatogram can be matched to a mass, confirming the main peak is the target and helping identify impurities. JPT Peptide Technologies describes HPLC-MS as its standard analytical tool for this reason.
Regulators rely on this kind of characterization. FDA’s 2021 guidance on generic versions of certain synthetic peptide drugs expects peptide-related impurities to be characterized, and says a proposed generic should not contain any new specified peptide-related impurity above 0.5% of the drug substance. RUO materials are not drugs and are not subject to that guidance, but it shows the analytical depth applied in regulated settings.
Other Tests You May See
| Test | Purpose |
|---|---|
| Amino acid analysis | Confirms composition and supports net peptide content |
| Karl Fischer titration | Measures residual water |
| Counterion analysis | Quantifies TFA, acetate, or chloride content |
| Appearance | Confirms physical form and color |
These fill the gaps HPLC and MS leave, particularly for calculating accurate solution concentrations. See our reconstitution guide for how net peptide content enters the math.
Method Validation and Why It Matters
A method should be shown fit for purpose. The ICH Q2(R2) guideline sets out validation characteristics for analytical procedures, including specificity, accuracy, precision, detection and quantitation limits, linearity, and range. A method that has not been shown to separate the relevant impurities cannot support a strong purity claim, however high the number.
Decoding “99% Purity” Claims
Ask four questions of any purity figure:
- Which lot? A purity number must be tied to a lot number that matches your vial.
- Which method? HPLC conditions and detection wavelength should be stated.
- Where is the data? A chromatogram and integration table should be available.
- Is identity confirmed? A matching mass spectrometry result should accompany it.
Without those, a percentage is a marketing claim. Our COA reading guide includes a full red-flag checklist.
Our Approach at A&A Wellness
Our standard: 99% purity, lab tested in the USA. Every A&A Wellness product is guaranteed to meet 99% purity and is lab tested in the USA. Learn more in our quality standards overview.
Key Takeaways
- HPLC measures purity as area percent of UV-detected peptide material under stated conditions.
- Mass spectrometry confirms identity by comparing observed and theoretical mass.
- Each has blind spots; used together (often as LC-MS), they are far more informative.
- A purity figure means little without a lot number, method, chromatogram, and identity confirmation.
Explore compound-specific background such as tirzepatide or MOTS-c, or browse Research Peptides.
Sources
- D'Hondt M, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014
- ICH Q2(R2) Validation of Analytical Procedures — Scientific Guideline (EMA)
- FDA. ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin. Guidance for Industry. 2021
- JPT Peptide Technologies. About Peptide Purity
